EN DE
Watch MARK2 CORPORATION for free: we tell you when fair value or trend changes.
Data-driven stock valuation

MARK2 CORPORATION (M2C) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of MARK2 CORPORATION stock CZK 255, price CZK 140, upside +81.8%, quality 44 out of 100. Rating: strongly undervalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials CZ · ISIN CZ1008000823

MC MARK2 CORPORATION logo Some data Nov 3, 2026

MARK2 CORPORATION

M2C · PR
Cheap, value-trap risk

The stock costs 45% less than our calculation considers fair.

Fair value 254.57 CZK · Strongly undervalued
Low debt
Even on cautious assumptions the value is 51% above the price (210.93 CZK).
Quality 44/100
Expensive Growth (revenue 3y +13.2 %/yr in CZK)
Thin margins · 0.4% net margin (TTM)
Mixed vs. peers (5/12)
Some data
Negative free cash flow
Narrow moat 27/100
Watch MARK2 CORPORATION for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

302.00 CZK 119.50 CZK Fair Value 254.57 CZK Jun 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.

How to read this chart

17‑month range 119.50 CZK – 302.00 CZK · fair‑value band 210.93 CZK – 310.53 CZK · the 140.00 CZK price screens below the 254.57 CZK fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.

Follow MARK2 in your weekly email

Every Wednesday you see whether MARK2 is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Mark2 Corporation Investment SE provides integrated facility management services in Europe.

Show moreShow less

The company engages in the provision of property and persons physical security services; planning and implementation of maintenance and repairs, as well as preventive and predictive maintenance; cleaning of administrative buildings, shopping centers, and industrial areas; and maintenance of lawns, gardens, terraces, and plant care in shopping centers or office buildings.

It also provides energy consumption management services; construction management services, such as interior remodeling, renovations, and equipment replacements; and smart building management technologies for building administration and security.

The company was founded in 1992 and is based in Prague, Czech Republic.

Stock analysis

MARK2 CORPORATION (M2C) currently trades at 140.00 CZK, while our model-based Fair Value estimate is 254.57 CZK, implying the stock looks roughly 45% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 436.95 CZK per share, and 7 of the 14 models we run sit above the 140.00 CZK price.

Bear case: the Growth Earnings group reads lowest at 76.83 CZK, and 7 of the 14 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 210.93 CZK (bear) to 310.53 CZK (bull), the price of 140.00 CZK sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 44/100 (below-average quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

MARK2 CORPORATION reported revenue of 4.6B CZK in FY2025 versus 3.2B CZK in FY2022, a compound +13.2%/yr. Reported net income was 18.8M CZK in FY2025, compounding −25.3%/yr from FY2022.

Key figures

Market cap 535M CZK (≈ $24.5M) Micro · P/E ratio 28.5 · P/S ratio 0.11 · EPS (TTM) 4.92 CZK · Net margin 0.4% · Return on equity 2.8% · Return on assets (EBIT) 9.6% (4-year average) · Operating margin 1.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 27 out of 100 (medium confidence).

What moves the price

The share trades about 48% below its 52-week high and 17% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −12% fair-value upside, at 82%, M2C screens cheaper than that median.

Fair Value models

Bear 210.93 CZK Fair Value 254.57 CZK Bull 310.53 CZK
Price 140.00 CZK · Upside +81.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (4.22 CZK per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV 210.84 CZK 237.51 CZK 260.09 CZK 71
ROIC Compounder 210.93 CZK 254.57 CZK 310.53 CZK 69
Residual Income 133.26 CZK 135.12 CZK 143.66 CZK 68
All 14 models by family
Earnings-Based
Graham-Dodd 33.45 CZK 119.08 CZK 160.35 CZK 61
Lynch FV 27.99 CZK 39.99 CZK 51.98 CZK 58
PEG = 1.0 27.99 CZK 39.99 CZK 51.98 CZK 55
EPV 210.84 CZK 237.51 CZK 260.09 CZK 71
Multiples
P/E Multiple 77.47 CZK 103.29 CZK 129.11 CZK 63
P/S Multiple 62.71 CZK 83.62 CZK 104.52 CZK 58
P/B Multiple 675.09 CZK 900.12 CZK 1,125 CZK 55
EV/EBIT 375.61 CZK 491.48 CZK 607.34 CZK 66
EV/EBITDA 411.78 CZK 539.71 CZK 667.63 CZK 67
EV/Revenue 276.10 CZK 382.42 CZK 488.75 CZK 54
Asset-Based
NCAV (Graham) 97.43 CZK 147.62 CZK 184.52 CZK 54
Economic Profit
Residual Income 133.26 CZK 135.12 CZK 143.66 CZK 68
ROIC Compounder 210.93 CZK 254.57 CZK 310.53 CZK 69
Growth Earnings
Growth-Adj P/E 53.78 CZK 76.83 CZK 99.87 CZK 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 44/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 52
How much profit the company makes from its sales and capital
Quality Growth 18
Are margins and returns getting better?
Cashflow 4
Do the profits arrive as real cash?
Financial strength 80
Debt, balance sheet and risk of trouble
Investment 42
Does it invest with discipline instead of growing at any price?
Low Volatility 56
How calm the share price moves, does not count
Price momentum 14
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 7
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 56/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+2.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.2%
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+1.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.3%
Dividend (yield on the price)0.0%

Watch M2C, get fair value alerts →

Compare MARK2 CORPORATION with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 229 stocks

Beats the industry median on 5/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 44 · Bottom 25%
Fair Value upside +85.8% · Top 25%
Profitability
Return on equity (12 months) 2.8% · Below median
Return on assets 1.2% · Below median
Net margin (12 months) 0.4% · Bottom 25%
Operating margin (12 months) 1.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 0.0% · Below median
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/E (12 months) 28.5× · Pricier than median
P/B 0.65× · Cheapest 25%
P/S (12 months) 0.11× · Cheapest 25%
EV/EBITDA 3.4× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 45
FUTURE (revenue growth)0 · sector 33
PAST (return on equity)11 · sector 38
HEALTH (low debt)98 · sector 94
DIVIDEND (yield)0 · sector 57

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Copart, Inc CPRT $31.95 $35.15 +10% vs M2C
RB Global, Inc RBA C$131.85 C$145.04 +10% vs M2C
Wolters Kluwer N.V WKL €90.08 €98.05 +9% vs M2C
Global Payments Inc GPN $97.40 $87.83 −10% vs M2C
Brambles Limited BXB A$21.79 A$19.10 −12% vs M2C
Cintas Corporation CTAS $222.36 $188.90 −15% vs M2C
Rentokil Initial plc RTO $23.61 $19.63 −17% vs M2C
Thomson Reuters Corporation TRI $112.57 $70.75 −37% vs M2C
Aramark ARMK $52.54 $23.04 −56% vs M2C
UL Solutions Inc ULS $78.65 $33.46 −57% vs M2C

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

MARK2 CORPORATION: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "MARK2 CORPORATION Fair Value". https://www.fairvalue-calculator.com/stock/M2C

Frequently asked questions

Is MARK2 CORPORATION (M2C) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 254.57 CZK versus a price of 140.00 CZK, about +82% upside (undervalued).
What is the fair value of M2C?
Our model-based fair value for MARK2 CORPORATION is 254.57 CZK (as of Nov 3, 2026), built from audited fundamentals. The current price: 140.00 CZK.
What is the quality score of M2C?
MARK2 CORPORATION has a Quality Score of 44/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MARK2 CORPORATION (M2C)?
Our model-based price target is the fair value of 254.57 CZK (as of Nov 3, 2026) from 14 valuation models. Cautious scenario 210.93 CZK, optimistic scenario 310.53 CZK. It is a calculation from audited fundamentals, not an analyst target.
What is the MARK2 CORPORATION stock forecast for 2026?
Our models put fair value at 254.57 CZK, about +82% upside versus a price of 140.00 CZK (undervalued). Cautious scenario 210.93 CZK, optimistic scenario 310.53 CZK. The calculation is refreshed regularly with new filings.
What is the revenue of MARK2 CORPORATION (M2C)?
MARK2 CORPORATION reported trailing-twelve-month revenue of about 4.6B CZK (latest available figure, as of Nov 3, 2026).
What is the intrinsic value of MARK2 CORPORATION (M2C)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MARK2 CORPORATION it is 254.57 CZK per share (as of Nov 3, 2026), against a price of 140.00 CZK. It is the blended result of 14 valuation models in 5 families (Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is MARK2 CORPORATION stock overvalued or undervalued in 2026?
As of Nov 3, 2026, M2C trades below its calculated fair value: price 140.00 CZK, fair value 254.57 CZK, a gap of about +82% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of M2C?
No. The price is what the market pays today (140.00 CZK); the fair value is what the company's own numbers justify (254.57 CZK). For MARK2 CORPORATION the two are 114.57 CZK per share apart. That gap is exactly why we show both numbers side by side.
How much is MARK2 CORPORATION worth?
The market values MARK2 CORPORATION at about 535M CZK (market capitalisation, as of Nov 3, 2026). Per share that is 140.00 CZK; our models calculate a fair value of 254.57 CZK per share.
What do the bullish and bearish scenarios say about M2C?
Our models span a range for MARK2 CORPORATION: cautious scenario 210.93 CZK, base 254.57 CZK, optimistic 310.53 CZK per share (as of Nov 3, 2026, price 140.00 CZK). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of M2C?
MARK2 CORPORATION trades at a price-to-earnings ratio of 28.5 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 254.57 CZK is built from several models across several years. Other multiples: P/B 0.7, P/S 0.1, EV/EBITDA 3.4.
How solid is the balance sheet of MARK2 CORPORATION (M2C)?
Balance-sheet figures for MARK2 CORPORATION (as of Nov 3, 2026): return on equity 2.8%, debt of 0.03 per unit of equity. They feed the Quality Score of 44/100, which measures business quality independently of the share price.
How far is M2C from its 52-week high?
MARK2 CORPORATION trades at 140.00 CZK, about 48% below its 52-week high of 268.00 CZK and 17% above the low of 119.50 CZK (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 254.57 CZK is for.
Which stocks are comparable to MARK2 CORPORATION?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MARK2 CORPORATION stock attractive at the current price?
The data as of Nov 3, 2026: price 140.00 CZK, calculated fair value 254.57 CZK (+82%), Quality Score 44/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of M2C calculated?
We run MARK2 CORPORATION through 14 models from 5 families: Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 254.57 CZK builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. MARK2 CORPORATION currently trades 45% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MARK2 CORPORATION (M2C)?
The closing price on Nov 9, 2026 was 140.00 CZK. Our model-based fair value is 254.57 CZK, about +82% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MARK2 CORPORATION right now?
The large discount to fair value meets weak quality (44/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (210.93 CZK). The market is more pessimistic than our downside scenario.

Key figures of MARK2 CORPORATION

How large is the market capitalisation of MARK2 CORPORATION (M2C)?
The market capitalisation of MARK2 CORPORATION is 535M CZK (≈ $24.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MARK2 CORPORATION (M2C)?
The price-to-sales ratio of MARK2 CORPORATION is 0.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MARK2 CORPORATION (M2C)?
Earnings per share at MARK2 CORPORATION are 4.92 CZK (price ÷ EPS = P/E 28.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of MARK2 CORPORATION (M2C)?
The net margin of MARK2 CORPORATION is 0.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MARK2 CORPORATION (M2C)?
The return on equity (ROE) of MARK2 CORPORATION is 2.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MARK2 CORPORATION (M2C)?
On an EBIT basis the return on assets of MARK2 CORPORATION is 9.6% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MARK2 CORPORATION (M2C)?
The operating margin of MARK2 CORPORATION is 1.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does MARK2 CORPORATION (M2C) generate?
The free cash flow of MARK2 CORPORATION is −215M CZK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch MARK2 CORPORATION in the live analysis

One click puts MARK2 CORPORATION on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.